Académique Documents
Professionnel Documents
Culture Documents
Moderator : Dr. dr. Sagung Rai Indrasari, M.Kes., Sp.T.H.T.K.L (K), FICS
1
therapy is recommended if symptoms do not availability of the antibiotic, the concerns of
improve or persist or worsen after the third the parents about the possible side effects,
day. 5 or development of complications. 5
2
nasal discharge (+) and oedem of inferior rhinosinusitis is based on a medical history
concha. On dental examination is not found to find out whether rhinosinusitis is
abnormality, no caries dentis. On recurrent and a physical exam of the nose.
oropharynx examination tonsil T1-T1, with This can give clue whether the cause is
no hyperemic mucosa and detritus (-). On bacterial or viral or other. 2
indirect laryngoscopy examination is not
found abnormality. Neck examination is not From the anamnesis, patient came with
3
patient often felt fever and nasal congestion The American Academy of Pediatrics
since 2 months before and missing out. Viral states that some children with persistent
upper respiratory tract infections are the sinusitis symptoms may overcome the
most common predisposing factor for disease through their immune systems and
bacterial sinusitis. It has been demonstrated that the risk of suppurative complications is
that the prevalence of upper respiratory tract low in such patients. Therefore they
infections is increasing the prevalence of recommend short term followup in selected
rhinosinusitis. Viral sinusitis leads to nasal patients or antibiotic therapy. 7
congestion and abnormal mucosal activity.
Bacteria or fungi increase the risk of Persistent acute bacterial sinusitis can
secondary infections.6 affect the quality of life of patients mildly
(cough-nasal discharge) or seriously (sleep
In physical examination, patient disturbance, school failure). Decision of
temperature is 38.5 and form anterior follow-up or antibiotherapy is evaluated
rhinoscopy, we can see purulent discharge, based on the severity of the symptoms, how
and oedema of inferior concha. they affect the quality of life of the patient,
recent history of antibiotic use, current
Vasodilation associated with mediators,
experience relating to acute sinusitis, the
increased mucosal secretion, plasma
cost and availability of the antibiotic, the
extravasation, neurogenic inflammation and
concerns of the parents about the possible
mast cell-nerve interactions can be seen.
side effects, or development of
Inflammation leads to local changes that
contribute to the development of complications.8
infection.6
Antibiotic therapy is recommended if
the patient received antibiotic therapy
Rhinosinusitis should be considered
within the last four weeks but have
rather than acute viral upper respiratory
concurrent bacterial infection (pneumonia,
tract infection, and antibiotic therapy should
suppurative lymphadenitis, group A
be recommended if body temperature is
betahemolytic streptococcal pharyngitis or
rapidly increasing and/ or above 39°C and
acute otitis media), has complications or
purulent nasal discharge lasting longer than
suspected complications, has asthma, cystic
three days is present. Similiarly, antibiotic
fibrosis, immunodeficiency or a history of
therapy is recommended if symptoms do not
sinus surgery, has an anatomical
improve or persist or worsen after the third
abnormality in the upper respiratory tract.9
day. 7
4
Penicillin should be preferred for the antibiotic. An additional dose of ceftriaxone
first-line treatment. It is recommended may be administered before switching to
because of its efficacy, safety, affordability, oral antibiotic in symptomatic children
pleasant flavor and narrow microbiological whose fever persists despite the treatment. 9
spectrum. 45mg/kg/day as two doses is Studies have demonstrated that the risk of
recommended in children with acute allergic reactions that may develop with the
bacterial sinusitis who are followed-up use of 2nd or 3rd generation
without complications and who have not cephalosphorins in patients who are allergic
received antibiotics for the last 4 weeks to penicillin or amoxicillin is almost the
while 80-90 mg/kg/day as two doses (max 2 same as in those who are nonallergic to
g/day) is recommended in populations with these agents. Therefore cefdinir, cefuroxime
high resistance to pneumococci. 8 and cefpodoxime can be safely used in
patients with allergies of non-type 1
Penicillin still the treatment of choice hypersensitivity reaction9 S. pneumoniae
for this case, and amplified aminopenicillins and H. influenzae are sensitive to cefdinir,
have grown usefulness in performance with cefuroxime and cefpodoxime at rates of 60-
the growing incidence of beta-lactamase 75% and 85-100%, respectively.10
producing bacteria. The penicillin,
Cefixime and clindamycin (or
especially in children and adolescents,
linezolid) combination may be preferred to
display the highest advantage for it being
be attentive to the resistance of S.
lowest cost. Treatment with high dose (80-
pneumoniae and H.influenza in children of
90 mg/kg/day) is recommended in sinusitis
< 2 years of age with moderate/severe
patients aged < 2 years who present with
bacterial sinusitis who have serious allergic
moderate or severe clinical symptoms.
reaction to penicillin. Linezolid is an
Parenteral single dose 50 mg/kg ceftriaxone
antibiotic that is highly sensitive even
may be administered to patients who vomit
against penicillin-resistant S.pneumoniae
or cannot tolerate oral therapy.
but poorly effective against H.influenzae
Ceftriaxone is an agent which has been
and M.catarrhalis. No oral preparation of
demonstrated to be effective against the
linezolid is available in our country. In areas
identified microorganisms in acute bacterial
with high resistance to penicillin, it has been
sinusitis in 95-100% of the cases. If
demonstrated that using TMPSMX and
improvement is observed within 24 hours
azithromycin is not useful since
after administration of ceftriaxone,
pneumococci strains are resistant to these
treatment may be continued with an oral
agents 10
5
No optimal duration of antibiotic days ago. The patient felt difficult to
therapy has been specified; however it is breathing because of nasal congestion,
stated that the duration of therapy will vary cough and fever since 7 days ago. The
between 10 and 28 days. Another patient also felt facial pain especially n
recommendation is to continue the cheek area. Before chief complain, patient
antibiotic therapy for 7 days after resolution never had similar complain before. But the
of the signs and symptoms. 10 patient often felt fever and nasal congestion
since 2 months before and missing out.
As a general rule, prevention of risk Sleep apnea, halitosis, and snooring was
factors can help avoid development of denied. Ear and nose complaints are denied.
rhinosinusitis. These include environmental Patient claims, there is no history of Allergy
pollutants, upper airway infections, daycare and Asthma.
centre attendance, nasal allergies, and
From physical examination from on
anatomical aberrations. These should be
rhinoscopy anterior examination anterior
managed on a war footing in order to avoid
rhinoscopy nasal discharge (+) and oedem
their development into rhinosinusitis. Acute
of inferior concha.
attacks of rhinosinusitis should be optimally
managed to prevent progress to chronicity.
The patient was diagnosed with acute
Influenza and pneumococcal vaccines could
rhinosinusitis. In this patient, have been
also lead to fall in upper airway infections
treated by antipiretic and antibiotic.
2
and hence rhinosinusitis.
6
MMSc, and Wanda Phipatanakul, MD,
MS. Pediatric
Rhinosinusitis. 2017
5. Ellen R Wald, MD, Sheldon L
Kaplan, MD, Robert A Wood, MD,
Glenn C Isaacson, MD, FAAP.
Acute bacterial rhinosinusitis in
children: Clinical features and
diagnosis. 2019
6. Ferguson BJ, Orlandi RR: Chronic
Hypertrophic Rhinosinusitis and
Nasal Polyposis. In: Baley BJ &
Johnson JT, Head & Neck
SurgeryOtolaryngology. 5th edition.
Lippincott Williams & Wilkins
2014: p 394-403
7. Walsh WE, Kern RC: Sinonasal
Anatomy, Function, and
Evaluation. In: Baley BJ & Johnson
JT, Head & Neck
SurgeryOtolaryngology. 5th edition.
Lippincott Williams & Wilkins
2014: p 308-314
8. Busquets JM, Hwang PH:
Nonpolypoid Rhinosinusitis:
Classification, Diagnosis, and
Treatment. In Baley BJ & Johnson
JT, Head & Neck
SurgeryOtolaryngology, 5th edition,
Lippincott Williams & Wilkins
2014: p 405-416
9. Zhang Y, Gevaert E, Lou H, Wang,
X, Zhang L, Bachert C, & Zhang N.
Chronic rhinosinusitis in Asia.
Journal of Allergy and Clinical
Immunology. 2017. 140(5), 1230 –
1239.
10. Busquets JM, Hwang PH. Non
polypoid Rhinosinusitis:
Classification, Diagnosis, and
Treatment. In Baley BJ & Johnson
JT, Head & Neck Surgery
Otolaryngology. 5th edition.
Lippincott Williams & Wilkins.
2014.P: 525-534.